Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
The Commonwealth of Massachusetts v. Mylan Laboratories, Inc. et al
Case Number:
1:03-cv-11865
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Ballard Spahr
- Birnbaum & Godkin
- Cetrulo LLP
- Clark Hunt
- Dentons
- DLA Piper
- Dueffert Gilbertsen
- Eckert Seamans
- Fitch Law Partners
- Foley Hoag
- Foley & Lardner
- Greenberg Traurig
- Hagens Berman
- Hyman Phelps
- Irell & Manella
- Katten Muchin
- Kelley Drye
- Kirkland & Ellis
- K&L Gates
- Marcus Neiman
- Prince Lobel
- Ropes & Gray
- Russ August & Kabat
- Sherin & Lodgen
- Sulloway & Hollis
- Vorys
- Williams & Connolly
Companies
- Allergan PLC
- Bristol-Myers Squibb Co.
- Cardinal Health Inc.
- Mylan NV
- Par Pharmaceutical Cos. Inc.
- Teva Pharmaceutical Industries Ltd.
- Unisys Corp.
Sectors & Industries:
-
September 30, 2010
Merck Balks At $4.6M Verdict In Mass. Medicaid Case
Merck & Co. Inc. vowed Thursday to fight a $4.6 million jury verdict against the drugmaker in a suit alleging that a defunct subsidiary of Schering-Plough Corp. — which is now owned by Merck — reported inflated prices for albuterol to the Massachusetts Medicaid program.
-
March 09, 2010
Actavis Settles Mass. Medicaid Price Claims For $4M
Actavis Elizabeth LLC has paid $3.6 million to settle the state of Massachusetts' allegations that it jacked up the prices of drugs sold to the state's Medicaid program, becoming the latest pharmaceutical giant to have struck such a deal.
-
February 16, 2010
Watson Settles Mass. Medicaid Fraud Suit For $2.4M
Agreeing to pay $2.4 million, Watson Pharmaceuticals Inc. has become the latest drug giant to settle claims brought by the Massachusetts attorney general that it defrauded the state's Medicaid program into overpaying for prescription drugs.
-
August 26, 2009
Mass. AG Accuses Mylan, Others Of Medicaid Fraud
Massachusetts Attorney General Martha Coakley has accused Mylan Laboratories Inc. and other pharmaceutical companies of systematically reporting false and inflated prices for products purchased by the state's Medicaid program that resulted in millions of dollars in overpayments by taxpayers.
-
March 12, 2009
Mylan Denied Summary Judgment In Antitrust Case
A federal judge has refused Mylan Laboratories Inc.'s bid to dismiss claims related to the anti-anxiety drug lorazepam in a lawsuit alleging the drugmaker conspired with competitors to inflate drug prices.
-
January 05, 2009
Teva, Mass. Settle Drug Price-Fixing Suit For $7M
Teva Pharmaceutical USA Inc. has agreed to pay $7 million to settle allegations of drug price-fixing brought by the Massachusetts Attorney General's Office as part of a multidistrict litigation accusing a handful of pharmaceutical companies of falsely inflating the prices of drugs.
-
September 22, 2008
Roxane Settles Price Inflation Suit For $1.8M
Generic-drug maker Boehringer Ingelheim Roxane Inc. has agreed to pay Massachusetts' state Medicaid program $1.8 million to settle a lawsuit alleging that it defrauded the program by overstating the cost of drugs.